High-rolling investors have positioned themselves bearish on Novo Nordisk (NYSE:NVO), and it's important for retail traders to take note.This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in NVO often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Novo Nordisk. This is not a typical pattern.
The sentiment among these major traders is split, with 36% bullish and 45% bearish. Among all the options we identified, there was one put, amounting to $94,500, and 10 calls, totaling $494,105.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $124.0 to $165.0 for Novo Nordisk over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale trades within a strike price range from $124.0 to $165.0 in the last 30 days.
Novo Nordisk Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
| NVO | PUT | SWEEP | BULLISH | 08/09/24 | $1.97 | $1.75 | $1.75 | $125.00 | $94.5K | 471 | 606 |
| NVO | CALL | SWEEP | BULLISH | 08/16/24 | $10.3 | $10.1 | $10.1 | $124.00 | $75.7K | 167 | 0 |
| NVO | CALL | SWEEP | BULLISH | 08/09/24 | $4.15 | $4.0 | $4.15 | $133.00 | $68.9K | 126 | 581 |
| NVO | CALL | SWEEP | NEUTRAL | 08/09/24 | $6.35 | $6.1 | $6.21 | $129.00 | $62.7K | 891 | 280 |
| NVO | CALL | SWEEP | BEARISH | 01/17/25 | $3.7 | $3.55 | $3.55 | $165.00 | $57.5K | 1.5K | 164 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Novo Nordisk's Current Market Status
- With a volume of 1,387,583, the price of NVO is up 2.38% at $132.31.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 7 days.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Novo Nordisk with Benzinga Pro for real-time alerts.
高额投资者已将自己定位为看跌诺和诺德（纽约证券交易所代码：NVO），散户交易者注意这一点很重要。\ 这项活动今天通过Benzinga对公开期权数据的追踪引起了我们的注意。这些投资者的身份尚不确定，但是NVO的如此重大举措通常表明有人拥有特权信息。
今天，Benzinga的期权扫描仪发现了Novo Nordisk的11笔期权交易。这不是典型的模式。
这些主要交易者的情绪分歧，36％看涨，45％看跌。在我们确定的所有期权中，有一个看跌期权，金额为94,500美元，还有10个看涨期权，总额为494,105美元。
预测的价格区间
考虑到这些合约的交易量和未平仓合约，在过去的3个月中，鲸鱼似乎一直将Novo Nordisk的价格定在124.0美元至165.0美元之间。
交易量和未平仓合约的发展
交易期权时，查看交易量和未平仓合约是一个强有力的举动。这些数据可以帮助您跟踪Novo Nordisk期权在给定行使价下的流动性和利息。下面，我们可以观察过去30天内诺和诺德所有鲸鱼交易的看涨和看跌期权交易量和未平仓合约的变化，其行使价在124.0美元至165.0美元之间。
诺和诺德期权活动分析：过去 30 天
观察到的最大期权交易：
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|
NVO | PUT | SWEEP | BULLISH | 08/09/24 | $1.97 | $1.75 | $1.75 | $125.00 | $94.5K | 471 | 606 |
NVO | CALL | SWEEP | BULLISH | 08/16/24 | $10.3 | $10.1 | $10.1 | $124.00 | $75.7K | 167 | 0 |
NVO | CALL | SWEEP | BULLISH | 08/09/24 | $4.15 | $4.0 | $4.15 | $133.00 | $68.9K | 126 | 581 |
NVO | CALL | SWEEP | NEUTRAL | 08/09/24 | $6.35 | $6.1 | $6.21 | $129.00 | $62.7K | 891 | 280 |
NVO | CALL | SWEEP | BEARISH | 01/17/25 | $3.7 | $3.55 | $3.55 | $165.00 | $57.5K | 1.5K | 164 |
关于 Novo Nordisk
诺和诺德拥有全球品牌糖尿病治疗市场约三分之一的份额，是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦，生产和销售各种人用和现代胰岛素、注射型糖尿病治疗药物（如 GLP-1 疗法）、口服抗糖尿病药物和肥胖疗法。Novo还有一个生物制药板块（约占收入的10％），专门研究血友病和其他疾病的蛋白质疗法。
诺和诺德的当前市场状况
NVO的交易量为1,387,583美元，上涨2.38％，至132.31美元。
RSI 指标暗示，标的股票目前在超买和超卖之间保持中立。
下一份财报预计将在7天后公布。
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用 Benzinga Pro 了解诺和诺德的最新期权交易，获取实时提醒。
